Intracerebral metastases of malignant melanoma and their recurrences - A clinical analysis

Clinical Neurology and Neurosurgery

Volumn 115, Issue 9, 2013, Pages 1721-1728

  Miller, Dorothea ^a   Zappala, Valeria ^b   El Hindy, Nicolai ^a   Livingstone, Elisabeth ^a   Schadendorf, Dirk ^a   Sure, Ulrich ^a   Sandalcioglu, Ibrahim Erol ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Brain metastasis; Malignant melanoma; Neurosurgery; Prognostic factors; Recurrence; Reoperation

Indexed keywords

ANTINEOPLASTIC AGENT; INTERFERON;

AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOCAL THERAPY; MALE; MELANOMA; MICROSURGERY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; RETROSPECTIVE STUDY; STEREOTACTIC BIOPSY; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; SURVIVAL TIME;

BRAIN METASTASIS; MALIGNANT MELANOMA; NEUROSURGERY; PROGNOSTIC FACTORS; RECURRENCE; REOPERATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LYMPHATIC METASTASIS; MALE; MELANOMA; MICROSURGERY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; PALLIATIVE CARE; PROGNOSIS; RADIOSURGERY; SURVIVAL ANALYSIS;

EID: 84887619332     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2013.03.019     Document Type: Article

References (35)

1. R.E. Sawaya, R.K. Bindal, F.F. Lang, and D. Abi-Said Metastatic brain tumors A.H. Kaye, E.R.J. Laws, Brain Tumors 2001 Curchill Livingstone Philadelphia 999 1026
2. J.S. Barnholtz-Sloan, A.E. Sloan, F.G. Davis, F.D. Vigneau, P. Lai, and R.E. Sawaya Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System Journal of Clinical Oncology 22 2004 2865 2872
3. B.E. Harrison, J.L. Johnson, R.W. Clough, and E.C. Halperin Selection of patients with melanoma brain metastases for aggressive treatment American Journal of Clinical Oncology 26 2003 354 357
4. A. Houghton, D. Coit, W. Bloomer, A. Buzaid, D. Chu, and B. Eisenburgh NCCN melanoma practice guidelines National Comprehensive Cancer Network Oncology (Williston Park) 12 1998 153 177
5. M.H. Amer, M. Al-Sarraf, L.H. Baker, and V.K. Vaitkevicius Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival Cancer 42 1978 660 668
6. D.R. Budman, E. Camacho, and R.E. Wittes The current causes of death in patients with malignant melanoma European Journal of Cancer 14 1978 327 330
7. D.E. Bullard, E.B. Cox, and H.F. Seigler Central nervous system metastases in malignant melanoma Neurosurgery 8 1981 26 30
8. A.J. Patel, D. Suki, M.A. Hatiboglu, H. Abouassi, W. Shi, and D.M. Wildrick Factors influencing the risk of local recurrence after resection of a single brain metastasis Journal of Neurosurgery 113 2010 181 189
9. M.A. Davies, P. Liu, S. McIntyre, K.B. Kim, N. Papadopoulos, and W.J. Hwu Prognostic factors for survival in melanoma patients with brain metastases Cancer 117 2011 1687 1696
10. T.K. Eigentler, A. Figl, D. Krex, P. Mohr, C. Mauch, and K. Rass Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma Cancer 117 2011 1697 1703
11. K.M. Fife, M.H. Colman, G.N. Stevens, I.C. Firth, D. Moon, and K.F. Shannon Determinants of outcome in melanoma patients with cerebral metastases Journal of Clinical Oncology 22 2004 1293 1300
12. J.H. Sampson, J.H. Carter Jr., A.H. Friedman, and H.F. Seigler Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma Journal of Neurosurgery 88 1998 11 20
13. J.M. Skibber, S.J. Soong, L. Austin, C.M. Balch, and R.E. Sawaya Cranial irradiation after surgical excision of brain metastases in melanoma patients Annals of Surgical Oncology 3 1996 118 123
14. M.S. Mitchell Relapse in the central nervous system in melanoma patients successfully treated with biomodulators Journal of Clinical Oncology 7 1989 1701 1709
15. M. Salvati, A. Frati, A. D'Elia, L. Pescatori, M. Piccirilli, and A. Pietrantonio Single brain metastases from melanoma: remarks on a series of 84 patients Neurosurgical Review 35 2012 211 218
16. M. Wronski, and E. Arbit Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients Journal of Neurosurgery 93 2000 9 18
17. A.C. Zacest, M. Besser, G. Stevens, J.F. Thompson, W.H. McCarthy, and G. Culjak Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades Journal of Neurosurgery 96 2002 552 558
18. C.M. Balch, J.E. Gershenwald, S.J. Soong, J.F. Thompson, M.B. Atkins, and D.R. Byrd Final version of 2009 AJCC melanoma staging and classification Journal of Clinical Oncology 27 2009 6199 6206
19. L.E. Gaspar, C. Scott, K. Murray, and W. Curran Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases International Journal of Radiation Oncology, Biology, Physics 47 2000 1001 1006
20. M. Staudt, K. Lasithiotakis, U. Leiter, F. Meier, T. Eigentler, and M. Bamberg Determinants of survival in patients with brain metastases from cutaneous melanoma British Journal of Cancer 102 2010 1213 1218
21. J. Zakrzewski, L.N. Geraghty, A.E. Rose, P.J. Christos, M. Mazumdar, and D. Polsky Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival Cancer 117 2011 1711 1720
22. R.R. Lonser, D.K. Song, J. Klapper, M. Hagan, S. Auh, and P.B. Kerr Surgical management of melanoma brain metastases in patients treated with immunotherapy Journal of Neurosurgery 115 2011 30 36
23. K. Margolin, M.S. Ernstoff, O. Hamid, D. Lawrence, D. McDermott, and I. Puzanov Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology 13 2012 459 465
24. D. Mathieu, D. Kondziolka, P.B. Cooper, J.C. Flickinger, A. Niranjan, and S. Agarwala Gamma knife radiosurgery in the management of malignant melanoma brain metastases Neurosurgery 60 2007 471 481
25. Y. Mori, D. Kondziolka, J.C. Flickinger, J.M. Kirkwood, S. Agarwala, and L.D. Lunsford Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival International Journal of Radiation Oncology, Biology, Physics 42 1998 581 589
26. A.E. Radbill, J.F. Fiveash, E.T. Falkenberg, B.L. Guthrie, P.E. Young, and S. Meleth Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity Cancer 101 2004 825 833
27. U. Selek, E.L. Chang, S.J. Hassenbusch 3rd, A.S. Shiu, F.F. Lang, and P. Allen Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases International Journal of Radiation Oncology, Biology, Physics 59 2004 1097 1106
28. C. Yu, J.C. Chen, M.L. Apuzzo, S. O'Day, S.L. Giannotta, and J.S. Weber Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery International Journal of Radiation Oncology, Biology, Physics 52 2002 1277 1287
29. N.A. Hagen, C. Cirrincione, H.T. Thaler, and L.M. DeAngelis The role of radiation therapy following resection of single brain metastasis from melanoma Neurology 40 1990 158 160
30. G.T. Gibney, P.A. Forsyth, and V.K. Sondak Melanoma in the brain: biology and therapeutic options Melanoma Research 22 2012 177 183
31. S. Jang, and M.B. Atkins Which drug, and when, for patients with BRAF-mutant melanoma? The Lancet Oncology 14 2013 e60 e69
32. G.V. Long, U. Trefzer, M.A. Davies, R.F. Kefford, P.A. Ascierto, and P.B. Chapman Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial The Lancet Oncology 13 2012 1087 1095
33. J.H. Ahn, S.H. Lee, S. Kim, J. Joo, H. Yoo, and S.H. Lee Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection Journal of Neurosurgery 116 2012 984 993
34. E. Arbit, M. Wronski, M. Burt, and J.H. Galicich The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer Cancer 76 1995 765 773
35. R.K. Bindal, R. Sawaya, M.E. Leavens, K.R. Hess, and S.H. Taylor Reoperation for recurrent metastatic brain tumors Journal of Neurosurgery 83 1995 600 604